Borecka, Oktawia
Llewellyn, Samuel https://orcid.org/0000-0001-5216-4216
Woollacott, Ione
Richardson, Lucy
Fellows, Alasdair
Lawrence, Jack
Bottomley, Catherine
Biggane, Alice M.
Funding for this research was provided by:
Pfizer UK (N/A)
Article History
Received: 8 August 2025
Accepted: 23 March 2026
First Online: 10 April 2026
Declarations
:
: Ethical approval for this study was granted by a central independent review board (Solutions IRB, Yarnell, AZ, US). All participants provided informed consent electronically prior to undertaking any protocol-related activities.
: Participant data has been anonymized, and participants were informed that if information about this study was published, they would not be identified.
: AMB and LR are employees of Pfizer Ltd. IW was an employee of Pfizer Ltd. during the conduct of this study. AF, JL and SL are employees of Vitaccess, which served as a paid consultant to Pfizer Ltd. in connection with the conduct of this study and the development of this manuscript. OB was an employee of Vitaccess during the conduct of this study and development of this manuscript and is now an employee of OPEN Health. CB was an employee of Vitaccess during the conduct of this study and development of this manuscript and is now an employee of Clarivate.